• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Diagnostic tools
      • Research team
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

Study Type: Real-World Evidence

Birkeland Kåre I., Bodegard Johan, Eriksson Jan W., Norhammar Anna, Thuresson Marcus, Pignot Marc, Garal-Pantaler Elena, Yajima Toshitaka, Komuro Issei, Kadowaki Takashi, Cardiorenal disease is the most common first CV manifestation in type 2 diabetes and associated with increased mortality: a large multinational observational study European Association for the Study of Diabetes 55th Annual Meeting. 2019;
Birkeland Kåre I., Bodegard Johan, Norhammar Anna, Kuiper JG, Georgiado E., Beekman- Hendriks WL, Thuresson Marcus, Pignot Marc, Herings RMC, Kooy A., How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study. Diabetes Obes Metab. 2019; 10.1111/dom.13612.
Kraus MR, Kleine H., Thönnes S., Pignot Marc, Sanchez Gonzalez Y., Improvement of Hepatic and Extrahepatic Complications from Chronic Hepatitis C After Antiviral Treatment: A Retrospective Analysis of German Sickness Fund Data. Infect Dis Ther.. 2018; 7(3):339-352. 10.1007/s40121-018-0205-2.
Kraus MR, Kleine H., Thönnes S., Pignot Marc, Sanchez Gonzalez Y., Clinical and Economic Burden of Hepatic and Extrahepatic Complications from Chronic Hepatitis C: A Retrospective Analysis of German Sickness Fund Data. Infect Dis Ther. 2018; Sep;7(3):327-338. 10.1007/s40121-018-0204-3.
Hammond E. R., Friedel H., Garal-Pantaler Elena, Pignot Marc, Velthuis E., Wang X., Nab H., Desta Barnabas, Schwarting Andreas, Health Care Resource Use (HRU) and Medical Costs Analyses as a Function of Systemic Lupus Erythematosus (SLE) Disease Severity: Analysis of Claims Data of a German Sickness Fund. LUPUS. 2018; 5(Suppl 1): A1–A129. 10.1136/lupus-2018-abstract.204.
Hammond E. R., Friedel H., Garal-Pantaler Elena, Pignot Marc, Velthuis E., Wang X., Nab H., Desta Barnabas, Schwarting Andreas, Health Care Resource Utilisation (HCRU) and Cost Analyses of Systemic Lupus Erythematosus (SLE) as a Function of Disease Severity: Analysis of Real-World Claims Data from a German Sickness Fund. Ann. Rheum. Dis. 2018; 10.1136/annrheumdis-2018-eular.5150.
Klein AB, Shire N, Winget M, Wang H, Wilk A, Pignot Marc, Real-World Patient Characteristics And Patterns Of Care Among Metastatic Urothelial, Head And Neck, Non-Small Cell Lung Cancer Patients Using A German Sickness Fund Claims Database Value in Health, VOLUME 20. 2017; ISSUE 9: PA473. 10.1016/j.jval.2017.08.423.
Harrow B, Konieczny A, Pignot Marc, Wilk A, Bala M, Disease Burden During The “Watchful Waiting” Period In Women With Recurrent Ovarian Cancer In Germany Value in Health, VOLUME 20. 2017; ISSUE 9: PA465-A466. 10.1016/j.jval.2017.08.381.
  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3

sidebar

Search our Publications

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Real-World Evidence
  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Diagnostic tools
  • Data collection instruments

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2023 ZEG Berlin

Impressum

Website by Laura Yeffeth.